tenofovir + emtricitabine + efavirenz

DRUG2 trials

Sponsors

Juan A. Arnaiz

Conditions

HIV Infections

Phase 4

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

CompletedNCT00532168

Juan A. ArnaizHIV Infections

Start: 2007-09-30End: 2012-12-31Updated: 2013-02-22

Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism

Juan A. ArnaizHIV Infections

Start: 2008-09-30End: 2013-07-31Target: 50Updated: 2013-02-22

Related Papers

Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemia.

2018-06-0111 citations

Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1–Infected Patients Starting Efavirenz, Lopinavir–Ritonavir, or Atazanavir–Ritonavir Plus Tenofovir/Emtricitabine

JAIDS Journal of Acquired Immune Deficiency Syndromes2015-02-1415 citations

Differential Subcutaneous Adipose Tissue Gene Expression Patterns in a Randomized Clinical Trial of Efavirenz or Lopinavir-Ritonavir in Antiretroviral-Naive Patients

Antimicrobial Agents and Chemotherapy2014-08-263 citations